David Spirk

2.6k total citations
62 papers, 1.1k citations indexed

About

David Spirk is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, David Spirk has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Internal Medicine, 36 papers in Cardiology and Cardiovascular Medicine and 27 papers in Surgery. Recurrent topics in David Spirk's work include Venous Thromboembolism Diagnosis and Management (43 papers), Central Venous Catheters and Hemodialysis (19 papers) and Atrial Fibrillation Management and Outcomes (18 papers). David Spirk is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (43 papers), Central Venous Catheters and Hemodialysis (19 papers) and Atrial Fibrillation Management and Outcomes (18 papers). David Spirk collaborates with scholars based in Switzerland, Germany and Austria. David Spirk's co-authors include Nils Kucher, Rolf P. Engelberger, Iris Baumgärtner, Anna K. Stuck, Marc Husmann, Tim Sebastian, Torsten Willenberg, Martin Banyai, Drahomir Aujesky and Beat Frauchiger and has published in prestigious journals such as Blood, European Heart Journal and Annals of Oncology.

In The Last Decade

David Spirk

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Spirk Switzerland 21 889 512 468 350 115 62 1.1k
Noémie Kraaijpoel Netherlands 18 656 0.7× 379 0.7× 289 0.6× 204 0.6× 116 1.0× 36 1.0k
Damon E. Houghton United States 18 899 1.0× 668 1.3× 271 0.6× 287 0.8× 104 0.9× 95 1.2k
Sofia Barbar Italy 9 849 1.0× 509 1.0× 266 0.6× 152 0.4× 144 1.3× 13 1.1k
Tobias Tritschler Switzerland 14 1.0k 1.1× 475 0.9× 276 0.6× 110 0.3× 187 1.6× 61 1.5k
Marica Perlati Italy 5 799 0.9× 486 0.9× 256 0.5× 139 0.4× 131 1.1× 6 972
Ricardo Pavanello Brazil 9 990 1.1× 767 1.5× 316 0.7× 210 0.6× 127 1.1× 20 1.2k
Michele G. Beckman United States 14 902 1.0× 518 1.0× 264 0.6× 170 0.5× 112 1.0× 36 1.2k
Cynthia Wu Canada 17 834 0.9× 558 1.1× 239 0.5× 184 0.5× 115 1.0× 55 1.1k
Renée A. Douma Netherlands 18 1.1k 1.3× 532 1.0× 317 0.7× 263 0.8× 242 2.1× 38 1.4k
Cathy Emery United States 9 856 1.0× 529 1.0× 286 0.6× 219 0.6× 90 0.8× 11 936

Countries citing papers authored by David Spirk

Since Specialization
Citations

This map shows the geographic impact of David Spirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Spirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Spirk more than expected).

Fields of papers citing papers by David Spirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Spirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Spirk. The network helps show where David Spirk may publish in the future.

Co-authorship network of co-authors of David Spirk

This figure shows the co-authorship network connecting the top 25 collaborators of David Spirk. A scholar is included among the top collaborators of David Spirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Spirk. David Spirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rexhaj, Emrush, Sarah Bär, Rodrigo Soria, et al.. (2024). Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy. Atherosclerosis. 392. 117504–117504. 8 indexed citations
2.
Sebastian, Tim, Stefano Barco, Michael Lichtenberg, et al.. (2024). The TOPOS study. VASA. 53(3). 217–224. 3 indexed citations
3.
4.
Spirk, David, Tim Sebastian, Jürg H. Beer, et al.. (2021). Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER). Internal and Emergency Medicine. 17(3). 799–803. 4 indexed citations
5.
Sebastian, Tim, et al.. (2021). Pulmonary embolism and deep vein thrombosis: Similar but different. Thrombosis Research. 206. 88–98. 38 indexed citations
6.
Sebastian, Tim, Stefano Barco, Rolf P. Engelberger, et al.. (2020). Duplex Ultrasound Investigation for the Detection of Obstructed Iliocaval Venous Stents. European Journal of Vascular and Endovascular Surgery. 60(3). 443–450. 19 indexed citations
7.
Spirk, David, Tim Sebastian, Stefano Barco, et al.. (2020). Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER). Thrombosis and Haemostasis. 121(5). 641–649. 9 indexed citations
8.
Zanchin, Christian, Yasushi Ueki, Sylvain Losdat, et al.. (2020). In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study. European Heart Journal - Cardiovascular Imaging. 22(7). 824–834. 20 indexed citations
9.
Spirk, David, et al.. (2020). First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH). Frontiers in Cardiovascular Medicine. 7. 46–46. 5 indexed citations
10.
Sebastian, Tim, David Spirk, Rolf P. Engelberger, et al.. (2019). Incidence of Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with the Postthrombotic Syndrome. Thrombosis and Haemostasis. 119(12). 2064–2073. 31 indexed citations
11.
Sebastian, Tim, David Spirk, Frederic Baumann, et al.. (2018). Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis. Thrombosis Research. 172. 86–93. 28 indexed citations
12.
Blondon, Marc, David Spirk, Nils Kucher, et al.. (2018). Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients. Thrombosis and Haemostasis. 118(1). 82–89. 23 indexed citations
13.
Spirk, David, et al.. (2017). Electronic alert system for improving appropriate thromboprophylaxis in hospitalized medical patients: a randomized controlled trial. Journal of Thrombosis and Haemostasis. 15(11). 2138–2146. 20 indexed citations
14.
Aujesky, Drahomir, Jürg H. Beer, Lucia Mazzolai, et al.. (2016). Rivaroxaban for the treatment of venous thromboembolism. Thrombosis and Haemostasis. 116(9). 472–479. 36 indexed citations
15.
Spirk, David, Mathieu Nendaz, Drahomir Aujesky, et al.. (2015). Predictors of thromboprophylaxis in hospitalised medical patients. Thrombosis and Haemostasis. 113(5). 1127–1134. 10 indexed citations
16.
Engelberger, Rolf P., Torsten Willenberg, Frederic Baumann, et al.. (2014). Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis. Thrombosis and Haemostasis. 111(6). 1153–1160. 46 indexed citations
17.
Spirk, David, Martin Banyai, Vincenzo Jacomella, et al.. (2011). Outpatient management of acute deep vein thrombosis: Results from the OTIS-DVT registry. Thrombosis Research. 127(5). 406–410. 14 indexed citations
18.
Nendaz, Mathieu, Pierre Chopard, Christian Lovis, et al.. (2010). Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems. Journal of Thrombosis and Haemostasis. 8(6). 1230–1234. 31 indexed citations
19.
Willenberg, Torsten, Martin Banyai, Thomas Baldi, et al.. (2010). Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Thrombosis and Haemostasis. 105(2). 239–244. 8 indexed citations
20.
Siebenrock, Klaus A., U Metzger, E. Mouhsine, et al.. (2009). Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Thrombosis and Haemostasis. 102(7). 56–61. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noémie Kraaijpoel Breakdown of academic impact, for papers by Damon E. Houghton Breakdown of academic impact, for papers by Sofia Barbar Breakdown of academic impact, for papers by Tobias Tritschler Breakdown of academic impact, for papers by Marica Perlati Breakdown of academic impact, for papers by Ricardo Pavanello Breakdown of academic impact, for papers by Michele G. Beckman Breakdown of academic impact, for papers by Cynthia Wu Breakdown of academic impact, for papers by Renée A. Douma Breakdown of academic impact, for papers by Cathy Emery
Rankless by CCL
2026